Active Learner

Never give up, great things take time. Follow ⚔️Endorsement | Follow me if you like my tweets

[Active Learner @GrowthInGrace]

Life’s a brutal climb. Wrong choices? They’ll knock you off the ladder. I’ve fallen—hard. Failures sting, but they teach. Dust off, learn, keep climbing. Hope fuels the comeback. Struggle’s real, but so is growth. #LifeLessons @chamath @BillAckman @elonmusk happy Father’s Day to three men I look up and hope to learn from each and every day!

[Active Learner @GrowthInGrace]

@_WinDiesel How about now lol! 😂

[Active Learner @GrowthInGrace]

@_WinDiesel Gap filled, $ktos climb will be wild

[Active Learner @GrowthInGrace]

@WallStSai $rvmd $regn

[Active Learner @GrowthInGrace]

@Banana_Oncology @Pharmdca Maybe a partnership on the lead asset, not a complete buyout! $25b for just the pdac indication!

[Active Learner @GrowthInGrace]

@BigChodu @TheIpHawk Yikes, indeed, $abvx will be lower than 50 tomorrow, long road ahead!

[Active Learner @GrowthInGrace]

@Sanctuary_Bio If as good as what’s on the market, what is the need for undue cancer risk $abvx - no Bd anytime soon

[Active Learner @GrowthInGrace]

@Lord_of_Biotech In pharma when you have numerical imbalance in malignancies - commercially and from BD pov - cooked @Banana_Oncology

[Active Learner @GrowthInGrace]

@WallStSai $smmt goes quick with approval around the corner

[Active Learner @GrowthInGrace]

@BiotechTV @YaleCancer @DrRoyHerbst He knows OS, $smmt will show clear benefit!

[Active Learner @GrowthInGrace]

@LoyalTipsters02 Arsenal 1 - 0, and goal in 2H only

[Active Learner @GrowthInGrace]

@DrSamuelBHume @Biomaven This is why $rvmd and $Smmt will be bought before YE!

[Active Learner @GrowthInGrace]

@elonmusk @EndWokeness @cb_doge So sorry to hear that, Elon - prayers to the family

[Active Learner @GrowthInGrace]

@DGretta_Author $AMZN will buy $Hims to own the healthcare / pharma sector consumer! Huge tam for $amzn to add

[Active Learner @GrowthInGrace]

@agingroy One of the top five either buyout $rvmd or partner in its next $50 billion dollar onco franchise! Better yet $NVDA should buy it and AI the heck out of cancer tech! That would be true Revolution! @Banana_Oncology

[Active Learner @GrowthInGrace]

@adamfeuerstein This I agree with! Though @DrMakaryFDA is doing phenomenal to accelerate the FDA

[Active Learner @GrowthInGrace]

@DrPaulyDeSantis @Bigpharmalover It reminded me of Imbruvica type play, too big for a single partner deal, even bigger because of the tam here! I expect $MRK, $Jnj and maybe $LLY to partner! Total deal could be over $50b at launch

[NBC News @NBCNews]

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say. https://t.co/HAGhnYB5eo

[NBC News @NBCNews]

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say. https://t.co/kaw026NO9G

[Active Learner @GrowthInGrace]

@NBCNews Great news, @DrMakaryFDA faster approval please, patients cannot wait, dying day by day! Unfortunately